|Mr. Joseph C. Sardano||Chairman, CEO & Pres||538.39k||N/A||1953|
|Mr. Arthur R. Levine||Chief Financial Officer||389.82k||N/A||1958|
|Mr. Stephen Cohen||Exec. VP of Strategic Initiatives & Dermatology Sales||478.62k||N/A||1960|
|Mr. Kalman Fishman||COO & Chief Technology Officer||N/A||N/A||1971|
|Dr. Ziv Karni||Chief Scientific Officer||N/A||N/A||1945|
Sensus Healthcare, Inc. manufactures and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary robotic intraoperative radiation therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. has a research and development agreement with the Perelman School of Medicine at the University of Pennsylvania to collaborate on clinical research and development for robotic intraoperative radiation therapy system. The company was founded in 2010 and is headquartered in Boca Raton, Florida.
Sensus Healthcare, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.